Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:monoclonal_antibody |
| gptkbp:ATCCode |
gptkb:L04AC10
|
| gptkbp:CASNumber |
815610-63-0
|
| gptkbp:developedBy |
gptkb:AbbVie
|
| https://www.w3.org/2000/01/rdf-schema#label |
briakinumab
|
| gptkbp:intendedUse |
treatment of psoriasis
|
| gptkbp:legalStatus |
development discontinued
|
| gptkbp:macromoleculeType |
gptkb:IgG1_kappa
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:synonym |
ABT-874
|
| gptkbp:target |
gptkb:interleukin-12
gptkb:interleukin-23 |
| gptkbp:UNII |
6QY1D43K2F
|
| gptkbp:bfsParent |
gptkb:interleukin-12
gptkb:IL-12 |
| gptkbp:bfsLayer |
8
|